Skip to content

WST

West Pharmaceutical Services, Inc.

Revenue to net income

Key figures

MetricLast 12 months5-year CAGR
Revenue$3.4B+7.4%
Gross profit$1.3B+7.5%
Operating income$780M+7.5%
Net income$639M+7.4%
EPS$8.91+8.2%
Free cash flow$453M+9.5%